Search - tctmd.com

Displaying 201 - 220 of 3594

Sort: Relevancy | Date

Presentation TCT 2016

Out-of-Hospital Cardiac Arrest: Who Benefits By an Immediate Invasive Strategy?

Presenter: Cindy L. Grines, Holger Thiele, Christian M. Spaulding

October 31, 2016

Presentation TCT 2016

ABSORB China Clinical Outcomes at 2 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Runlin Gao

October 31, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Ileana L. Pina

October 31, 2016

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty VI: Cardiac Implants

Presenter: Ted Feldman, Scott Lim, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty V: Valcare

Presenter: Ted Feldman, Scott Lim, David Meerkin

October 31, 2016

Presentation TCT 2016

Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCA Culprit and Proximal LAD Non-Culprit Lesion

Presenter: Ran Kornowski, Michel R. Le May, Natalia Pinilla-Echeverri

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty IV: Millipede

Presenter: Ted Feldman, Scott Lim, Jason H. Rogers

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Presenter: Ran Kornowski, Michel R. Le May, Tej Sheth

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Presenter: Ted Feldman, Scott Lim, Horst Sievert

October 31, 2016

Presentation TCT 2016

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Presenter: Elazer R. Edelman, Juan F. Granada

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Presenter: Ted Feldman, Scott Lim, Azeem Latib

October 31, 2016

Presentation TCT 2016

Assessment and Implications of Vasomotion: Implications for BRS

Presenter: Elazer R. Edelman, Juan F. Granada, Habib Samady

October 31, 2016

Presentation TCT 2016

Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only?

Presenter: Ran Kornowski, Michel R. Le May, Henning Kelbæk

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty I: Cardioband TF Trial Results and Future Directions

Presenter: Ted Feldman, Scott Lim, Francesco Maisano

October 31, 2016

Presentation TCT 2016

Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion, Recoil, Side Branches, and More

Presenter: Elazer R. Edelman, Juan F. Granada, Richard J. Rapoza

October 31, 2016

Presentation TCT 2016

Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them?

Presenter: Ran Kornowski, Michel R. Le May, Jose P.S. Henriques

October 31, 2016

Presentation TCT 2016

Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial and Other Experiences

Presenter: Ted Feldman, Scott Lim, Steven F. Bolling

October 31, 2016

Advertisement

Out-of-Hospital Cardiac Arrest: Who Benefits By an Immediate Invasive Strategy?

ABSORB China Clinical Outcomes at 2 Years

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

ABSORB II Clinical Outcomes at 3 Years

Direct Annuloplasty VI: Cardiac Implants

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Direct Annuloplasty V: Valcare

Case Presentation: Multivessel Disease in a Patient With Large Inferior STEMI With RCA Culprit and Proximal LAD Non-Culprit Lesion

Direct Annuloplasty IV: Millipede

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Assessment and Implications of Vasomotion: Implications for BRS

Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only?

Direct Annuloplasty I: Cardioband TF Trial Results and Future Directions

Benchtop Testing of BRS Mechanical Properties (General and Absorb Specific): Expansion, Recoil, Side Branches, and More

Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them?

Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial and Other Experiences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content